Cerebrospinal fluid biomarkers of Alzheimer's disease

被引:58
作者
Fagan, Anne M. [1 ]
Holtzman, David M.
机构
[1] Washington Univ, Sch Med, Dept Neurol, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; amyloid-beta; biomarkers; cerebrospinal fluid; preclinical Alzheimer's disease; tau; MILD COGNITIVE IMPAIRMENT; AMYLOID-BETA-PEPTIDES; PITTSBURGH COMPOUND-B; TRAUMATIC BRAIN-INJURY; CSF BIOMARKERS; A-BETA-42/A-BETA-40; RATIO; ENTORHINAL CORTEX; LONGITUDINAL CSF; TAU-PROTEINS; DIAGNOSIS;
D O I
10.2217/BMM.09.83
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Alzheimer's disease will reach epidemic proportions within the next 20-30 years if left unchecked. Currently, there are no treatments that prevent or slow Alzheimer's disease but many are being developed. Parallel efforts to develop biomarkers to aid in disease diagnosis and prognosis, and assess disease risk are currently underway. Clinicopathological and biomarker studies have demonstrated that Alzheimer's disease pathology can be detected preclinically. Using biomarkers to identify affected individuals prior to the onset of clinical symptoms and associated synaptic/neuronal loss should enable novel clinical trial design and early mechanism-based therapeutic intervention. This article summarizes the most promising cerebrospinal fluid biomarkers, highlights novel applications and current challenges, and provides a prediction on how the field may evolve in 5-10 years.
引用
收藏
页码:51 / 63
页数:13
相关论文
共 83 条
[1]   Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly [J].
Aizenstein, Howard Jay ;
Nebes, Robert D. ;
Saxton, Judith A. ;
Price, Julie C. ;
Mathis, Chester A. ;
Tsopelas, Nicholas D. ;
Ziolko, Scott K. ;
James, Jeffrey A. ;
Snitz, Beth E. ;
Houck, Patricia R. ;
Bi, Wenzhu ;
Cohen, Ann D. ;
Lopresti, Brian J. ;
DeKosky, Steven T. ;
Halligan, Edythe M. ;
Klunk, William E. .
ARCHIVES OF NEUROLOGY, 2008, 65 (11) :1509-1517
[2]   Amyloid load and cerebral atrophy in Alzheimer's disease:: An 11C-PIB positron emission tomography study [J].
Archer, Hilary A. ;
Edison, Paul ;
Brooks, David J. ;
Barnes, Jo ;
Frost, Chris ;
Yeatman, Toni ;
Fox, Nick C. ;
Rossor, Martin N. .
ANNALS OF NEUROLOGY, 2006, 60 (01) :145-147
[3]   Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo [J].
Bateman, Randall J. ;
Munsell, Ling Y. ;
Morris, John C. ;
Swarm, Robert ;
Yarasheski, Kevin E. ;
Holtzman, David M. .
NATURE MEDICINE, 2006, 12 (07) :856-861
[4]   A γ-Secretase Inhibitor Decreases Amyloid-β Production in the Central Nervous System [J].
Bateman, Randall J. ;
Siemers, Eric R. ;
Mawuenyega, Kwasi G. ;
Wen, Guolin ;
Browning, Karen R. ;
Sigurdson, Wendy C. ;
Yarasheski, Kevin E. ;
Friedrich, Stuart W. ;
DeMattos, Ronald B. ;
May, Patrick C. ;
Paul, Steven M. ;
Holtzman, David M. .
ANNALS OF NEUROLOGY, 2009, 66 (01) :48-54
[5]   Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias [J].
Bibl, M. ;
Mollenhauer, B. ;
Lewczuk, P. ;
Esselmann, H. ;
Wolf, S. ;
Trenkwalder, C. ;
Otto, M. ;
Stiens, G. ;
Ruether, E. ;
Kornhuber, J. ;
Wiltfang, J. .
MOLECULAR PSYCHIATRY, 2007, 12 (07) :671-680
[6]   CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia [J].
Bibl, M ;
Mollenhauer, B ;
Esselmann, H ;
Lewczuk, P ;
Klafki, HW ;
Sparbier, K ;
Smirnov, A ;
Cepek, L ;
Trenkwalder, C ;
Rüther, E ;
Kornhuber, J ;
Otto, M ;
Wiltfang, J .
BRAIN, 2006, 129 :1177-1187
[7]  
BIBL M, 2006, J NEURAL TRANSM, V10
[8]   Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury [J].
Blennow, K ;
Nellgård, B .
NEUROLOGY, 2004, 62 (01) :159-159
[9]   CSF markers for incipient Alzheimer's disease [J].
Blennow, K ;
Hampel, H .
LANCET NEUROLOGY, 2003, 2 (10) :605-613
[10]   Longitudinal stability of CSF biomarkers in Alzheimer's disease [J].
Blennow, Kaj ;
Zetterberg, Henrik ;
Minthon, Lennart ;
Lannfelt, Lars ;
Strid, Stig ;
Annas, Peter ;
Basun, Hans ;
Andreasen, Niels .
NEUROSCIENCE LETTERS, 2007, 419 (01) :18-22